GB0201477D0 - Methods of obtaining isoform specific expression in mammalian cells - Google Patents

Methods of obtaining isoform specific expression in mammalian cells

Info

Publication number
GB0201477D0
GB0201477D0 GBGB0201477.7A GB0201477A GB0201477D0 GB 0201477 D0 GB0201477 D0 GB 0201477D0 GB 0201477 A GB0201477 A GB 0201477A GB 0201477 D0 GB0201477 D0 GB 0201477D0
Authority
GB
United Kingdom
Prior art keywords
obtaining
methods
mammalian cells
specific expression
isoform specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0201477.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Novartis Forschungsstiftung
Original Assignee
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institut
Novartis Forschungsstiftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research, Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institut, Novartis Forschungsstiftung filed Critical Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Priority to GBGB0201477.7A priority Critical patent/GB0201477D0/en
Publication of GB0201477D0 publication Critical patent/GB0201477D0/en
Priority to PCT/EP2003/000611 priority patent/WO2003062414A2/en
Priority to JP2003562282A priority patent/JP2005514946A/ja
Priority to EP20030731698 priority patent/EP1470231A2/en
Priority to US10/502,235 priority patent/US20050148526A1/en
Priority to AU2003237703A priority patent/AU2003237703A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0201477.7A 2002-01-23 2002-01-23 Methods of obtaining isoform specific expression in mammalian cells Ceased GB0201477D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0201477.7A GB0201477D0 (en) 2002-01-23 2002-01-23 Methods of obtaining isoform specific expression in mammalian cells
PCT/EP2003/000611 WO2003062414A2 (en) 2002-01-23 2003-01-22 Methods of obtaining isoform specific expression in mammalian cells
JP2003562282A JP2005514946A (ja) 2002-01-23 2003-01-22 哺乳類細胞におけるアイソフォーム特異的発現を得る方法
EP20030731698 EP1470231A2 (en) 2002-01-23 2003-01-22 Methods of obtaining isoform specific expression in mammalian cells
US10/502,235 US20050148526A1 (en) 2002-01-23 2003-01-22 Methods of obtaining isoform specific expression in mammalian cells
AU2003237703A AU2003237703A1 (en) 2002-01-23 2003-01-22 Methods of obtaining isoform specific expression in mammalian cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0201477.7A GB0201477D0 (en) 2002-01-23 2002-01-23 Methods of obtaining isoform specific expression in mammalian cells

Publications (1)

Publication Number Publication Date
GB0201477D0 true GB0201477D0 (en) 2002-03-13

Family

ID=9929577

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0201477.7A Ceased GB0201477D0 (en) 2002-01-23 2002-01-23 Methods of obtaining isoform specific expression in mammalian cells

Country Status (6)

Country Link
US (1) US20050148526A1 (https=)
EP (1) EP1470231A2 (https=)
JP (1) JP2005514946A (https=)
AU (1) AU2003237703A1 (https=)
GB (1) GB0201477D0 (https=)
WO (1) WO2003062414A2 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2429814C (en) * 2000-12-01 2014-02-18 Thomas Tuschl Rna interference mediating small rna molecules

Also Published As

Publication number Publication date
US20050148526A1 (en) 2005-07-07
EP1470231A2 (en) 2004-10-27
WO2003062414A2 (en) 2003-07-31
JP2005514946A (ja) 2005-05-26
AU2003237703A1 (en) 2003-09-02
WO2003062414A3 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
AU2003295444A8 (en) Methods for in vitro expansion of hematopoietic stem cells
IL176010A0 (en) Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells
AU2003302701A8 (en) Method of dynamically culturing embryonic stem cells
ZA200509760B (en) Composition for maintaining organ and cell viability
GB2404665B (en) Cell culture
AU2003216822A8 (en) Stem cell culture
ZA200606198B (en) Cell cycle genes and related methods of using
SI1835022T1 (sl) Postopek gojenja celic in uporabe le-tega
AU2003280687A1 (en) Composition for culturing multipotent stem cells and utilization of the same
AU2003287521A8 (en) Pluripotent cells from monocytes, and methods of making and using pluripotent cells
AU2003254196A8 (en) Methods for producing biological substances in pigment-deficient mutants of bacillus cells
GB2422843B (en) Cell culture base
AU2003223661A8 (en) Methods of assaying for cell cycle modulators
AU2003230767A8 (en) Methods of promoting cell viability
AU2002309989A1 (en) Directed evolution of protein in mammalian cells
GB0201477D0 (en) Methods of obtaining isoform specific expression in mammalian cells
GB0304918D0 (en) Cell culture
DE60330223D1 (https=)
GB0207116D0 (en) Method of electrochemical cell analysis
EP1773985A4 (en) METHOD OF STIMULATING MAMMALIAN CELLS AND MAMMALIAN CELL
AU2003225076A8 (en) Inhibition of ii expression in mammalian cells
EP1563073A4 (en) PROTEIN PRODUCTION METHODS AND MODIFIED CELLS FOR USE IN SUCH METHODS
GB0315262D0 (en) Methods of cell culture
AU2003299879A1 (en) Methods and compositions for regulating cell cycle checkpoints
GB0219544D0 (en) Cell Culture

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)